Journey of Shield : For the women and children of 21st Century
Shield identifies the future market in Gynecology and begins to introduces products/brands in women’s healthcare
Shield began the journey with a promise to introduce novel therapeutic options for better clinical outcomes. It was all product all speciality to A to V
The Beginning
Shield started off its journey in 1995 as a team focussed on building solutions based on Novel Therapeutic options that generates better clinical outcomes for patients. In its first decade of operations Shield had expanded to several states in the country with a bouquet of products catering to Amino Acids to Vitamins (A to V). Yet some of Shield’s home-grown brands such as Rudimin, Benforce M, Onerve – thrusted by their differentiated solutions and unique product positioning enjoyed a strong patronage among Gyanec, GP/CPS, diabetologists. The emergence of Gyanecs’ as top patrons for Shield was providence, but something that the team leveraged very well.
Going Niche
The signal and the way forward were clear – “Acquiring strength and competitiveness in its niche area of focus”. Shield was ahead of its times in identifying “Lifestyle Induced Infertility” as a malaise that was going to demand the highest of therapeutic interventions for the woman. Collaboration of minds with scientific thought and creative solutions, resulted in a collection of products that gave gynaecologists a potent tool to combat infertility. Brand OVAA Shield addressed infertility at the levels of ovulation and implantation. Brand APCOD pioneered in addressing PCOS as the root cause to infertility. Brand ZOAMATES, addressed the much-ignored cause of Male Infertility.
The Spectrum
India was fast stepping to a new age of growth presenting a unique set of opportunities for its women. Yet scores of women were caught up in the throes of lifestyle & age-related ailments hampering their quality of life and overall wellness. Supporting women from “Menarche to Menopause” became the leading light for Shield in bringing out solutions that addressed the spectrum of issues that the Gyanec faced with her patients. Adhering to its core philosophy of “Safe, effective and Non-Hormonal” Shield advanced novel and cutting-edge solutions for a clutch of problems that limited modern women such as recurrent UTI, Bacterial vaginitis, painful menstruation and the crippling effects of “Menopause”. Shield was successfully evolving into a complete Gynaecological pharma company by providing “A to Z” solutions i.e. APCOD to ZOAMATES,
The Specialisation
While Shield’s organic solutions addressed lifestyle induced “Infertility”, Shield was also scanning the horizon for acquisition of assets that could augment its arsenal in combating other causes infertility. Acquisition of “Nutrisynapzz Therapeutix Solutions” and its brands gave shield the ability to participate in targeted interventions such as “Solution for DNA Fragmentation, Enhancement of oocyte quality, Overcoming Diminished Ovarian Reserve, Safe Embryo Implantation, prevention and treatment of Preeclampsia etc. The emergence of Shield as key player in the infertility market synergised with the boom for infertility treatments in the country. A strong vindication of its visionary start a decade earlier.
The Mother and Child story
Assaying of scientific evidence from research studies across the world is a continuous activity at Shield. While exploring the options for treatment of neonatal health issues at the pregnancy stage, Shield gained insights into the space of Cognitive health of newborn and young children. Thus, born were the collaboration and further acquisition of Brio Bliss Lifesciences and Shields venturing into Developmental Paediatrics. Today Shield is entrenched in developing the Growth Developmental and Behavioural Paediatrics (GDBP) practice that addresses “Cognitive health issues” – a scourge that is afflicts a large population of Indian’s young population. The solutions advanced by shield are “innovative, reliable and providing complete solution” as against the “outdated and partial treatment” solutions that are prevalent in the market.
Shield continues it efforts in being a responsible partner to the Indian Medical community in addressing the healthcare needs of women and child. Shield’s path and choice of solutions have been driven solely by scientific and ethical considerations – a clarion call that has resulted in its evolution from a regional Multivitamin company to one of a Niche “Women and Child” healthcare organisation.